The Effect of Tranexamic Acid on Calculated Total Blood Loss in Patients undergoing Revision Shoulder Arthroplasty
Brief description of study
The purpose of this research study is to evaluate how well Tranexamic Acid (TXA) reduces total blood loss, surgical drain output (fluids released at the site of surgery) and hematoma (collection of blood outside the vessels) formation in patients undergoing revision shoulder replacements compared to patients who do not receive TXA.
Clinical Study Identifier: s20-01617
ClinicalTrials.gov Identifier: NCT04650698
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
